The marketing numbers behind the BMS-Celgene deal
With Bristol-Myers Squibb’s acquisition of Celgene set to close in Q3, the two companies have some marketing shops in common.
Pharma
Day one at JP Morgan ‘19: Mega-deals, accessibility, and price gouging (by hotels)
Deals, access and pricing, and the cost of attending one of healthcare’s biggest events ruled day one buzz at the conference.
Johnson & Johnson tries to hold the line after baby powder exposés
The pharma company has put on a full-court press in response to reports by Reuters and The New York Times.
GSK and Pfizer to merge consumer healthcare brands
GSK would have more than two-thirds of equity in new company.
The ‘Southwest Airlines of healthcare’ and PwC’s other trends to watch in 2019
Issues from 2018 will again affect the industry in 2019, according to a report from the PwC Health Research Institute.
Revolutionary rules for innovation in pharma
Birthing innovation is hard for big business, and especially for Big Medical and Big Pharma.
‘The current system is flawed’: PhRMA’s Zirkelbach on pricing
Robert Zirkelbach, public affairs EVP at PhRMA, discussed the group’s legislative priorities at the Coalition for Healthcare Communication’s post-election conference on Tuesday.
Pharma must consider new approach to opioid crisis
As more and more people die from opioid overdoses, it’s time for pharma to own up to its collective responsibility and come up with a solution.
How to lower drug prices in the U.S.? Lots of suggestions, few viable solutions
A panel representing pharma, government payer, and policy analyst presented three potential big-picture goals to strive for.
Survey finds marketing salaries are up, but gender gap widens in life sci
Salaries surged 4.8% in 2018 and are up 18.2% the past two years. But while respondents report a high degree of job satisfaction, a growing gender gap in salary remains a black eye for the business.
